Publicaciones en colaboración con investigadores/as de Universidade da Coruña (50)

2023

  1. COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients

    BMC Health Services Research, Vol. 23, Núm. 1

  2. Corrigendum: CARB-ES-19 multicenter study of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli from all Spanish provinces reveals interregional spread of high-risk clones such as ST307/OXA-48 and ST512/KPC-3(Front. Microbiol., (2022), 13, (918362), 10.3389/fmicb.2022.918362)

    Frontiers in Microbiology

  3. Effect of miR-21 in mesenchymal stem cells-derived extracellular vesicles behavior

    Stem Cell Research and Therapy, Vol. 14, Núm. 1

  4. Organotin(IV)-Decorated Graphene Quantum Dots as Dual Platform for Molecular Imaging and Treatment of Triple Negative Breast Cancer

    Chemistry - A European Journal, Vol. 29, Núm. 60

  5. Prophage identification and molecular analysis in the genomes of Pseudomonas aeruginosa strains isolated from critical care patients

    mSphere

  6. Prophage identification and molecular analysis in the genomes of Pseudomonas aeruginosa strains isolated from critical care patients

    mSphere, Vol. 8, Núm. 4, pp. e0012823

  7. The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)

    Frontiers in Microbiology, Vol. 14

2022

  1. Analysis of the costs associated with the follow-up of HIV patients discontinuing antiretroviral treatment due to lack of effectiveness or unacceptable toxicity in Spain

    Farmacia Hospitalaria, Vol. 46, Núm. 6, pp. 327-334

  2. CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3

    Frontiers in Microbiology, Vol. 13

  3. Imipenem-Relebactam Susceptibility in Enterobacterales Isolates Recovered from ICU Patients from Spain and Portugal (SUPERIOR and STEP Studies)

    Microbiology spectrum, Vol. 10, Núm. 5, pp. e0292722

  4. In Vitro Activity of Cefepime-Taniborbactam against Carbapenemase-Producing Enterobacterales and Pseudomonas aeruginosa Isolates Recovered in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 66, Núm. 3

  5. In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP studies)

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 11, pp. 3163-3172

  6. Justification for 24/7 clinical microbiology services

    Enfermedades Infecciosas y Microbiologia Clinica

  7. Multi-laboratory experiment PME11 for the standardization of phosphoproteome analysis

    Journal of Proteomics, Vol. 251

  8. Reverse Transcription-Loop-Mediated Isothermal Amplification-CRISPR-Cas13a Technology as a Promising Diagnostic Tool for SARS-CoV-2

    Microbiology spectrum, Vol. 10, Núm. 5, pp. e0239822

2021

  1. Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGS

    The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 2, pp. 370-379

2020

  1. (p)ppGpp and its role in bacterial persistence: New challenges

    Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 10

  2. Discrepancies Between GEMA and GINA in the Classification of Inhaled Corticosteroids

    Archivos de Bronconeumologia

  3. Erratum to Spanish Guidelines on the Evaluation and Diagnosis of Bronchiectasis in Adults [Arch Bronconeumol. 2018;54(2):79–87] (Archivos de Bronconeumologia (2018) 54(2) (79–87), (S0300289617302727), (10.1016/j.arbres.2017.07.015))

    Archivos de Bronconeumologia

  4. Genetic Predictors of Long-term Response to Antitumor Necrosis Factor Agents in Pediatric Inflammatory Bowel Disease

    Journal of pediatric gastroenterology and nutrition, Vol. 71, Núm. 4, pp. 508-515